Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Macrophage iron release is crucial for hair growth and wound healing.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Hair loss doesn't affect COVID-19 severity.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Social media data can help track and predict COVID-19 symptoms and trends.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

About 61% of women who had COVID-19 experienced hair loss afterward.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

Higher androgen levels might make COVID-19 worse, especially in men.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.